New patients in
Also the newly opened sites in Larisa, Erfurt and Mainz could recuit their first patient. Moreover, one more patient was recruited in Lausanne and six in Bern.In total 36 patients are participating in the trial.
First site in the Netherlands is recruiting
We very welcome Universitair Medische Centra in Amsterdam with their principal investigator Dr. Philip de Witt Hamer to the ReSurge trial team. Not long after recruitment start, the first patient was included into the RCT group – congratulations!